This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: University of California. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Igor Spigelman: Innovator in Cannabinoid Research
Introduction
Igor Spigelman is a notable inventor based in Los Angeles, CA. He has made significant contributions to the field of cannabinoid research, particularly in the development of compounds aimed at alleviating chronic pain. His work is recognized for its potential impact on pharmaceutical applications.
Latest Patents
Igor Spigelman holds a patent titled "Peripherally-acting cannabinoid receptor agonists for chronic pain." This patent encompasses peripherally acting cannabinoid agonist compounds, pharmaceutical compositions, and methods of using them. His innovative approach aims to provide new solutions for individuals suffering from chronic pain.
Career Highlights
Igor is affiliated with the University of California, where he continues to advance his research in cannabinoid therapies. His academic background and ongoing projects contribute to the growing body of knowledge in this important area of medicine.
Collaborations
Igor has collaborated with esteemed colleagues such as Craig Shiner and Herbert H. Seltzman. These partnerships enhance the research efforts and broaden the scope of their collective work in cannabinoid science.
Conclusion
Igor Spigelman is a pioneering inventor whose work in cannabinoid receptor agonists holds promise for chronic pain management. His contributions to the field are significant and reflect a commitment to advancing medical science.